Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges

International Diabetes Federation (2019). IDF Diabetes Atlas, International Diabetes Federation. [9th ed.]. Available online: https://www.diabetesatlas.org/en/.

American Diabetes Association (2021). 3. Prevention or delay of type 2 diabetes: Standards of medical care in Diabetes-2021. Diabetes Care, 44, S34–S39.

Landi, 2014, Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS), Age Ageing, 43, 748, 10.1093/ageing/afu115

Kalyani, 2014, Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases, Lancet Diabetes Endocrinol., 2, 819, 10.1016/S2213-8587(14)70034-8

American Diabetes Association (2021). 5. Facilitating behavior change and well-being to improve health outcomes: Standards of medical care in Diabetes-2021. Diabetes Care, 44, S53–S72.

American Diabetes Association (2021). 8. Obesity management for the treatment of type 2 diabetes: Standards of medical care in Diabetes-2021. Diabetes Care, 44, S100–S110.

Sievenpiper, 2018, Diabetes Canada Clinical Practice Guidelines Expert Committee. Nutrition therapy, Can. J. Diabetes, 42, S64, 10.1016/j.jcjd.2017.10.009

Franz, 2017, Academy of Nutrition and Dietetics Nutrition Practice Guideline for type 1 and type 2 diabetes in adults: Systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process, J. Acad. Nutr. Diet., 117, 1659, 10.1016/j.jand.2017.03.022

Associazione Medici Diabetologi (AMD), and Società Italiana di Diabetologia (SID) (2018). Standard Italiani per la Cura del Diabete, AMD, SID.

Leslie, W.S., Ford, I., Sattar, N., Hollingsworth, K.G., Adamson, A., Sniehotta, F.F., McCombie, L., Brosnahan, N., Ross, H., and Mathers, J.C. (2016). The Diabetes Remission Clinical Trial (DiRECT): Protocol for a cluster randomised trial. BMC Fam. Pract., 17.

Calugi, 2010, Lifestyle modification in the management of the metabolic syndrome: Achievements and challenges, Diabetes Metab. Syndr. Obes. Targets Ther., 3, 373, 10.2147/DMSO.S13860

National Institutes of Health (1980). Successful diet and exercise therapy is conducted in Vermont for “diabesity”. JAMA, 243, 519–520.

Astrup, 2000, Redefining type 2 diabetes: ‘Diabesity’ or ‘obesity dependent diabetes mellitus’?, Obes. Rev., 1, 57, 10.1046/j.1467-789x.2000.00013.x

Zimmet, P. (2000, January 17–21). The Negev desert, migration, islands and diabesity: Genes and environment clashing. Proceedings of the Cohen Memorial Lecture 36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem, Israel.

Flegal, 2009, Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults, Am. J. Clin. Nutr., 89, 500, 10.3945/ajcn.2008.26847

Wilson, 2003, Invited review: Aging and energy balance, J. Appl. Physiol., 95, 1728, 10.1152/japplphysiol.00313.2003

The Lancet Diabetes Endocrinology (2014). Sarcopenia: A fate worth challenging. Lancet Diabetes Endocrinol., 2, 183.

Marini, 2012, The potential of classic and specific bioelectrical impedance vector analysis for the assessment of sarcopenia and sarcopenic obesity, Clin. Interv. Aging, 7, 585, 10.2147/CIA.S38488

Buffa, R., Saragat, B., Cabras, S., Rinaldi, A.C., and Marini, E. (2013). Accuracy of specific BIVA for the assessment of body composition in the United States population. PLoS ONE, 8.

Bahat, 2019, Sarcopenia: Revised European consensus on definition and diagnosis, Age Ageing, 48, 16, 10.1093/ageing/afy169

Izzo, A., Massimino, E., Riccardi, G., and Della Pepa, G. (2021). A narrative review on sarcopenia in type 2 diabetes mellitus: Prevalence and associated factors. Nutrients, 13.

Anagnostis, 2020, Type 2 diabetes mellitus is associated with increased risk of sarcopenia: A systematic review and meta-analysis, Calcif. Tissue Int., 107, 453, 10.1007/s00223-020-00742-y

Solanki, 2015, Body composition in type 2 diabetes: Change in quality and not just quantity that matters, Int. J. Prev. Med., 6, 122, 10.4103/2008-7802.172376

Bawadi, H., Alkhatib, D., Abu-Hijleh, H., Alalwani, J., Majed, L., and Shi, Z. (2020). Muscle strength and glycaemic control among patients with type 2 diabetes. Nutrients, 12.

Lombardo, 2021, Relative handgrip strength is inversely associated with the presence of type 2 diabetes in overweight elderly women with varying nutritional status, Acta Diabetol., 58, 25, 10.1007/s00592-020-01588-4

Leenders, 2013, Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging, J. Am. Med. Dir. Assoc., 14, 585, 10.1016/j.jamda.2013.02.006

Veronese, 2019, Effect of nutritional supplementations on physical performance and muscle strength parameters in older people: A systematic review and meta-analysis, Ageing Res. Rev., 51, 48, 10.1016/j.arr.2019.02.005

Petersen, 2007, The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome, Proc. Natl. Acad. Sci. USA, 104, 12587, 10.1073/pnas.0705408104

Haedersdal, 2018, The role of glucagon in the pathophysiology and treatment of type 2 diabetes, Mayo Clin. Proc., 93, 217, 10.1016/j.mayocp.2017.12.003

Taylor, 2013, Type 2 diabetes: Etiology and reversibility, Diabetes Care, 36, 1047, 10.2337/dc12-1805

Galsgaard, 2018, Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis, Am. J. Physiol. Endocrinol. Metab., 314, E93, 10.1152/ajpendo.00198.2017

Faerch, 2018, Evidence of a liver-alpha cell axis in humans: Hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids, Diabetologia, 61, 671, 10.1007/s00125-017-4535-5

Younossi, 2019, The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis, J. Hepatol., 71, 793, 10.1016/j.jhep.2019.06.021

Felig, 1975, Amino acid metabolism in man, Annu. Rev. Biochem., 44, 933, 10.1146/annurev.bi.44.070175.004441

Forlani, 1984, Insulin-dependent metabolism of branched-chain amino acids in obesity, Metabolism, 33, 147, 10.1016/0026-0495(84)90127-6

Evert, 2019, Nutrition therapy for adults with diabetes or prediabetes: A consensus report, Diabetes Care, 42, 731, 10.2337/dci19-0014

Forouhi, 2018, Dietary and nutritional approaches for prevention and management of type 2 diabetes, BMJ, 361, k2234, 10.1136/bmj.k2234

Wang, 2018, Precision nutrition for prevention and management of type 2 diabetes, Lancet Diabetes Endocrinol., 6, 416, 10.1016/S2213-8587(18)30037-8

Ojo, O. (2019). Dietary intake and type 2 diabetes. Nutrients, 11.

Meng, 2017, Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: A systematic review and meta-analysis of randomized controlled trials, Diabetes Res. Clin. Pract., 131, 124, 10.1016/j.diabres.2017.07.006

Ojo, O., Ojo, O.O., Adebowale, F., and Wang, X.H. (2018). The effect of dietary glycaemic index on glycaemia in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Nutrients, 10.

Hamdy, 2016, Nutrition in Diabetes, Endocrinol. Metab. Clin. N. Am., 45, 799, 10.1016/j.ecl.2016.06.010

Vogtschmidt, 2021, Is protein the forgotten ingredient: Effects of higher compared to lower protein diets on cardiometabolic risk factors. A systematic review and meta-analysis of randomised controlled trials, Atherosclerosis, 328, 124, 10.1016/j.atherosclerosis.2021.05.011

Xue, 2021, Activity and bioavailability of food protein-derived angiotensin-I-converting enzyme-inhibitory peptides, Compr. Rev. Food Sci. Food Saf., 20, 1150, 10.1111/1541-4337.12711

Qian, 2016, Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Diabetes Care, 39, 1448, 10.2337/dc16-0513

Georgoulis, 2014, Mediterranean diet and diabetes: Prevention and treatment, Nutrients, 6, 1406, 10.3390/nu6041406

Preedy, V., and Watson, R. (2020). The Mediterranean diet and mineral composition. The Mediterranean Diet: An Evidence-Based Approach, Academic Press Books. [2nd ed.].

U.S. Department of Health and Human Services, and U.S. Department of Agriculture (2021, June 08). 2015–2020 Dietary Guidelines for Americans, 8th ed, Available online: http://health.gov/dietaryguidelines/2015/guidelines.

Campbell, 2017, DASH eating plan: An eating pattern for diabetes management, Diabetes Spectr., 30, 76, 10.2337/ds16-0084

Chester, 2019, The effects of popular diets on type 2 diabetes management, Diabetes Metab. Res. Rev., 35, e3188, 10.1002/dmrr.3188

Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N. Engl. J. Med., 344, 1343, 10.1056/NEJM200105033441801

The Diabetes Prevention Program Research Group (2002). The Diabetes Prevention Program (DPP): Description of lifestyle intervention. Diabetes Care, 25, 2165–2171.

The Look Ahead Research Group, Wadden, T.A., West, D.S., Delahanty, L., Jakicic, J., Rejeski, J., Williamson, D., Berkowitz, R.I., Kelley, D.E., and Tomchee, C. (2006). The Look AHEAD study: A description of the lifestyle intervention and the evidence supporting it. Obesity, 14, 737–752.

Wing, 2013, Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes, N. Engl. J. Med., 369, 145, 10.1056/NEJMoa1212914

Petroni, 2017, Long-term treatment of severe obesity: Are lifestyle interventions still an option?, Expert Rev. Endocrinol. Metab., 12, 391, 10.1080/17446651.2017.1386551

Ikramuddin, 2018, Lifestyle Intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the Diabetes Surgery Study, JAMA, 319, 266, 10.1001/jama.2017.20813

Lean, 2018, Primary care-led weight management for remission of type 2 diabetes (DiRECT): An open-label, cluster-randomised trial, Lancet, 391, 541, 10.1016/S0140-6736(17)33102-1

Lean, 2019, Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial, Lancet Diabetes Endocrinol., 7, 344, 10.1016/S2213-8587(19)30068-3

Taylor, 2018, Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but Is dependent upon capacity for beta cell recovery, Cell Metab., 28, 547, 10.1016/j.cmet.2018.07.003

2020, Improving type 2 diabetes mellitus glycaemic control through lifestyle modification implementing diet intervention: A systematic review and meta-analysis, Eur. J. Nutr., 59, 1313, 10.1007/s00394-019-02147-6

Grajower, M.M., and Horne, B.D. (2019). Clinical management of intermittent fasting in patients with diabetes mellitus. Nutrients, 11.

Rajpal, 2020, Intermittent fasting and ‘metabolic switch’: Effects on metabolic syndrome, prediabetes and type 2 diabetes, Diabetes Obes. Metab., 22, 1496, 10.1111/dom.14080

Horne, 2020, Limited evidence for the health effects and safety of intermittent fasting among patients with type 2 diabetes, JAMA, 324, 341, 10.1001/jama.2020.3908

Higgins, 2016, Smartphone applications for patients’ health and fitness, Am. J. Med., 129, 11, 10.1016/j.amjmed.2015.05.038

Michaelides, 2020, Mobile delivery of the Diabetes Prevention Program in people with prediabetes: Randomized controlled trial, JMIR mHealth uHealth, 8, e17842, 10.2196/17842

Stein, 2017, A fully automated conversational artificial intelligence for weight loss: Longitudinal cbservational study among overweight and obese ddults, JMIR Diabetes, 2, e28, 10.2196/diabetes.8590

Chin, 2016, Successful weight reduction and maintenance by using a smartphone application in those with overweight and obesity, Sci. Rep., 6, 34563, 10.1038/srep34563

Mazzotti, 2018, An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers, J. Hepatol., 69, 1155, 10.1016/j.jhep.2018.07.013

Nestler, 2015, Reflections on inositol(s) for PCOS therapy: Steps toward success, Gynecol. Endocrinol., 31, 501, 10.3109/09513590.2015.1054802

Unfer, 2016, Effects of inositol(s) in women with PCOS: A systematic review of randomized controlled trials, Int. J. Endocrinol., 2016, 1849162, 10.1155/2016/1849162

Larner, 2002, D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance, Int. J. Exp. Diabetes Res., 3, 47

Walters, 1992, Newly identified actions of the vitamin D endocrine system, Endocr. Rev., 13, 719

Pittas, 2007, The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults, Diabetes Care, 30, 980, 10.2337/dc06-1994

Wang, 2019, Vitamin D deficiency enhances insulin resistance by promoting inflammation in type 2 diabetes, Int J. Clin. Exp. Pathol, 12, 1859

Chiu, 2004, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction, Am. J. Clin. Nutr., 79, 820, 10.1093/ajcn/79.5.820

Bermudez, 2016, Pharmacological effects of niacin on acute hyperlipemia, Curr. Med. Chem., 23, 2826, 10.2174/0929867323666160411142909

Cicero, 2014, Nutraceuticals for metabolic syndrome management: From laboratory to benchside, Curr. Vasc. Pharmacol., 12, 565, 10.2174/15701611113119990120

Xia, 2017, Antioxidant effects of resveratrol in the cardiovascular system, Br. J. Pharmacol., 174, 1633, 10.1111/bph.13492

Al Bander, Z., Nitert, M.D., Mousa, A., and Naderpoor, N. (2020). The gut microbiota and inflammation: An overview. Int. J. Environ. Res. Public Health, 17.

Salazar, J., Angarita, L., Morillo, V., Navarro, C., Martinez, M.S., Chacin, M., Torres, W., Rajotia, A., Rojas, M., and Cano, C. (2020). Microbiota and diabetes mellitus: Role of lipid mediators. Nutrients, 12.

Tanase, D.M., Gosav, E.M., Neculae, E., Costea, C.F., Ciocoiu, M., Hurjui, L.L., Tarniceriu, C.C., Maranduca, M.A., Lacatusu, C.M., and Floria, M. (2020). Role of gut microbiota on onset and progression of microvascular complications of type 2 diabetes (T2DM). Nutrients, 12.

Tiderencel, 2020, Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials, Diabetes Metab. Res. Rev., 36, e3213, 10.1002/dmrr.3213

Woldeamlak, 2019, Role of gut microbiota in type 2 diabetes mellitus and its complications: Novel insights and potential intervention strategies, Korean J. Gastroenterol., 74, 314, 10.4166/kjg.2019.74.6.314

Shan, 2014, Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and type 2 diabetes, Diabetes, 63, 1796, 10.2337/db13-0606

Fukunaka, A., and Fujitani, Y. (2018). Role of zinc homeostasis in the pathogenesis of diabetes and obesity. Int. J. Mol. Sci., 19.

Maret, 2019, Chromium supplementation in human health, metabolic syndrome, and diabetes, Met. Ions Life Sci., 19, 231

Yang, 2006, Insulin-sensitizing and cholesterol-lowering effects of chromium (D-Phenylalanine)3, J. Inorg. Biochem., 100, 1187, 10.1016/j.jinorgbio.2006.01.039

Feng, 2020, Role of magnesium in type 2 diabetes mellitus, Biol. Trace Elem. Res., 196, 74, 10.1007/s12011-019-01922-0

Paolisso, 1997, Hypertension, diabetes mellitus, and insulin resistance: The role of intracellular magnesium, Am. J. Hypertens., 10, 346, 10.1016/S0895-7061(96)00342-1

Santamaria, 2019, Myo-inositol for the prevention of gestational diabetes mellitus. A brief review, J. Nutr. Sci. Vitaminol., 65, S59, 10.3177/jnsv.65.S59

Formoso, 2019, Inositol and antioxidant supplementation: Safety and efficacy in pregnancy, Diabetes Metab. Res. Rev., 35, e3154, 10.1002/dmrr.3154

Guardo, 2019, Non-pharmacological management of gestational diabetes: The role of myo-inositol, J. Complement. Integr. Med., 17, 20190111, 10.1515/jcim-2019-0111

Tahir, 2019, Inositol supplementation in the prevention of gestational diabetes mellitus, Cureus, 11, e5671

Brown, 2016, Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes, Cochrane Database Syst. Rev., 9, CD012048

Associazione Medici Diabetologi, and Società Italiana di Diabetologia (2021, June 08). Position Statement: Integratori Vitaminici, Inositolo e Probiotici nelle donne con Iperglicemia in Gravidanza. Available online: https://www.siditalia.it/news/2103-17-10-2018-position-statement-amd-sid-integratori-vitaminici-inositolo-e-probiotici-nelle-donne-con-iperglicemia-in-gravidanza.edn.

Omoruyi, F.O., Stennett, D., Foster, S., and Dilworth, L. (2020). New frontiers for the use of IP6 and inositol combination in treating diabetes mellitus: A review. Molecules, 25.

Davinelli, S., Nicolosi, D., Di Cesare, C., Scapagnini, G., and Di Marco, R. (2020). Targeting metabolic consequences of insulin resistance in polycystic ovary syndrome by D-chiro-inositol and emerging nutraceuticals: A focused review. J. Clin. Med., 9.

Cheng, 2010, Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study, Diabetes, 59, 242, 10.2337/db09-1011

Mitri, 2011, Vitamin D and type 2 diabetes: A systematic review, Eur. J. Clin. Nutr., 65, 1005, 10.1038/ejcn.2011.118

Ford, 2005, Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults, Diabetes Care, 28, 1228, 10.2337/diacare.28.5.1228

Scragg, 2004, Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey, Diabetes Care, 27, 2813, 10.2337/diacare.27.12.2813

Eliades, 2013, Meta-analysis: Vitamin D and non-alcoholic fatty liver disease, Aliment. Pharmacol. Ther., 38, 246, 10.1111/apt.12377

Lee, 2008, Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?, J. Am. Coll. Cardiol., 52, 1949, 10.1016/j.jacc.2008.08.050

Tai, 2008, Vitamin D, glucose, insulin, and insulin sensitivity, Nutrition, 24, 279, 10.1016/j.nut.2007.11.006

Avenell, 2009, Vitamin D supplementation and type 2 diabetes: A substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438), Age Ageing, 38, 606, 10.1093/ageing/afp109

Li, X., Liu, Y., Zheng, Y., Wang, P., and Zhang, Y. (2018). The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Nutrients, 10.

Niroomand, 2019, Does high-dose vitamin D supplementation impact insulin resistance and risk of development of diabetes in patients with pre-diabetes? A double-blind randomized clinical trial, Diabetes Res. Clin. Pract., 148, 1, 10.1016/j.diabres.2018.12.008

Polo, 1998, Nicotinamide improves insulin secretion and metabolic control in lean type 2 diabetic patients with secondary failure to sulphonylureas, Acta Diabetol., 35, 61, 10.1007/s005920050103

Xiang, 2020, Effectiveness of niacin supplementation for patients with type 2 diabetes: A meta-analysis of randomized controlled trials, Medicine, 99, e21235, 10.1097/MD.0000000000021235

Goldie, 2016, Niacin therapy and the risk of new-onset diabetes: A meta-analysis of randomised controlled trials, Heart, 102, 198, 10.1136/heartjnl-2015-308055

Landray, 2014, Effects of extended-release niacin with laropiprant in high-risk patients, N. Engl. J. Med., 371, 203, 10.1056/NEJMoa1300955

Swerdlow, 2015, HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials, Lancet, 385, 351, 10.1016/S0140-6736(14)61183-1

Rochlani, 2017, Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds, Ther. Adv. Cardiovasc. Dis., 11, 215, 10.1177/1753944717711379

Jin, 2018, Curcumin and other dietary polyphenols: Potential mechanisms of metabolic actions and therapy for diabetes and obesity, Am. J. Physiol. Endocrinol. Metab., 314, E201, 10.1152/ajpendo.00285.2017

Deyno, 2019, Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regression, Diabetes Res. Clin. Pract., 156, 107815, 10.1016/j.diabres.2019.107815

Yilmaz, 2017, Supplements for diabetes mellitus: A review of the literature, J. Pharm. Pract., 30, 631, 10.1177/0897190016663070

2013, Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion, Metab. Syndr. Relat. Disord., 11, 366, 10.1089/met.2012.0183

Yang, 2012, Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients, Evid. Based Complement. Alternat. Med., 2012, 363845, 10.1155/2012/363845

Gandhi, G.R., Vasconcelos, A.B.S., Wu, D.T., Li, H.B., Antony, P.J., Li, H., Geng, F., Gurgel, R.Q., Narain, N., and Gan, R.Y. (2020). Citrus flavonoids as promising phytochemicals targeting diabetes and related complications: A systematic review of in vitro and in vivo studies. Nutrients, 12.

Al-Aubaidy, H.A., Dayan, A., Deseo, M.A., Itsiopoulos, C., Jamil, D., Hadi, N.R., and Thomas, C.J. (2021). Twelve-week mediterranean diet intervention increases citrus bioflavonoid levels and reduces inflammation in people with type 2 diabetes mellitus. Nutrients, 13.

Chen, 2016, Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes, Mediat. Inflamm., 2016, 9340637, 10.1155/2016/9340637

Eid, 2017, The antidiabetic potential of quercetin: Underlying mechanisms, Curr. Med. Chem., 24, 355, 10.2174/0929867323666160909153707

Lahera, 2013, Aged garlic extract improves adiponectin levels in subjects with metabolic syndrome: A double-blind, placebo-controlled, randomized, crossover study, Mediat. Inflamm., 2013, 285795

Shang, A., Cao, S.Y., Xu, X.Y., Gan, R.Y., Tang, G.Y., Corke, H., Mavumengwana, V., and Li, H.B. (2019). Bioactive compounds and biological functions of garlic (Allium sativum L.). Foods, 8.

Zhu, 2019, Red yeast rice: A systematic review of the traditional uses, chemistry, pharmacology, and quality control of an important chinese folk medicine, Front. Pharmacol., 10, 1449, 10.3389/fphar.2019.01449

Saleem, 2018, A comprehensive review of phytochemical profile, bioactives for pharmaceuticals, and pharmacological attributes of Azadirachta indica, Phytother. Res., 32, 1241, 10.1002/ptr.6076

Huang, 2020, A review on the potential of resveratrol in prevention and therapy of diabetes and diabetic complications, Biomed. Pharmacother., 125, 109767, 10.1016/j.biopha.2019.109767

Jeyaraman, 2020, Resveratrol for adults with type 2 diabetes mellitus, Cochrane Database Syst. Rev., 1, CD011919

Ozturk, 2017, Resveratrol and diabetes: A critical review of clinical studies, Biomed. Pharmacother., 95, 230, 10.1016/j.biopha.2017.08.070

Chen, 2015, Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial, Dig. Liver Dis., 47, 226, 10.1016/j.dld.2014.11.015

Petroni, M.L., Brodosi, L., Marchignoli, F., Musio, A., and Marchesini, G. (2019). Moderate alcohol intake in non-alcoholic fatty liver disease: To drink or not to drink?. Nutrients, 11.

Plows, 2019, Nutritional supplementation for the prevention and/or treatment of gestational diabetes mellitus, Curr. Diabetes Rep., 19, 73, 10.1007/s11892-019-1199-1

Taylor, B.L., Woodfall, G.E., Sheedy, K.E., O’Riley, M.L., Rainbow, K.A., Bramwell, E.L., and Kellow, N.J. (2017). Effect of probiotics on metabolic outcomes in pregnant women with gestational diabetes: A systematic review and meta-analysis of randomized controlled trials. Nutrients, 9.

Bock, 2021, The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: A systematic review and meta-analysis, Diabetologia, 64, 26, 10.1007/s00125-020-05295-1

Aoun, 2020, The influence of the gut microbiome on obesity in adults and the role of probiotics, prebiotics, and synbiotics for weight loss, Prev. Nutr. Food Sci., 25, 113, 10.3746/pnf.2020.25.2.113

Greger, 2020, A whole food plant-based diet is effective for weight loss: The evidence, Am. J. Lifestyle Med., 14, 500, 10.1177/1559827620912400

Wang, 2019, Inulin-type fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations: Results from a GRADE-assessed systematic review and dose-response meta-analysis of 33 randomized controlled trials, J. Transl. Med., 17, 410, 10.1186/s12967-019-02159-0

Gao, 2019, Resistant starch ameliorated insulin resistant in patients of type 2 diabetes with obesity: A systematic review and meta-analysis, Lipids Health Dis., 18, 205, 10.1186/s12944-019-1127-z

Rao, 2019, Effect of inulin-type carbohydrates on insulin resistance in patients with type 2 diabetes and obesity: A systematic review and meta-analysis, J. Diabetes Res., 2019, 5101423, 10.1155/2019/5101423

Kaur, 2014, Micronutrient status in type 2 diabetes: A review, Adv. Food Nutr. Res., 71, 55, 10.1016/B978-0-12-800270-4.00002-X

Kazi, 2008, Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients, Biol. Trace Elem. Res., 122, 1, 10.1007/s12011-007-8062-y

Overbeck, 2008, Modulating the immune response by oral zinc supplementation: A single approach for multiple diseases, Arch. Immunol. Ther. Exp., 56, 15, 10.1007/s00005-008-0003-8

Jansen, 2009, Zinc and diabetes—Clinical links and molecular mechanisms, J. Nutr. Biochem., 20, 399, 10.1016/j.jnutbio.2009.01.009

Ruz, 2019, Nutritional effects of zinc on metabolic syndrome and type 2 diabetes: Mechanisms and main findings in human studies, Biol. Trace Elem. Res., 188, 177, 10.1007/s12011-018-1611-8

Jayawardena, 2012, Effects of zinc supplementation on diabetes mellitus: A systematic review and meta-analysis, Diabetol Metab. Syndr., 4, 13, 10.1186/1758-5996-4-13

Anderson, 2001, Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus, J. Am. Coll. Nutr., 20, 212, 10.1080/07315724.2001.10719034

Farvid, 2005, Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes, Diabetes Care, 28, 2458, 10.2337/diacare.28.10.2458

Parham, 2008, Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: A double blind, randomized, placebo-controlled, cross-over trial, Rev. Diabet. Stud., 5, 102, 10.1900/RDS.2008.5.102

Roussel, 2003, Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus, J. Am. Coll. Nutr., 22, 316, 10.1080/07315724.2003.10719310

Marchesini, 1998, Zinc supplementation improves glucose disposal in patients with cirrhosis, Metabolism, 47, 792, 10.1016/S0026-0495(98)90114-7

Marchesini, 1996, Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis, Hepatology, 23, 1084, 10.1002/hep.510230523

Morgan, 2007, The treatment of hepatic encephalopathy, Metab. Brain Dis., 22, 389, 10.1007/s11011-007-9060-7

Huang, 2006, The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: A systematic review for a National Institutes of Health state-of-the-science conference, Ann. Intern. Med., 145, 372, 10.7326/0003-4819-145-5-200609050-00135

Chen, S., Jin, X., Shan, Z., Li, S., Yin, J., Sun, T., Luo, C., Yang, W., Yao, P., and Yu, K. (2017). Inverse association of plasma chromium levels with newly diagnosed type 2 diabetes: A case-control study. Nutrients, 9.

Basaki, 2012, Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus, Biol. Trace. Elem. Res., 148, 161, 10.1007/s12011-012-9360-6

Suksomboon, 2014, Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes, J. Clin. Pharm. Ther., 39, 292, 10.1111/jcpt.12147

Yin, 2015, Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus, Nutr. J., 14, 14, 10.1186/1475-2891-14-14

Costello, 2016, Chromium supplements for glycemic control in type 2 diabetes: Limited evidence of effectiveness, Nutr. Rev., 74, 455, 10.1093/nutrit/nuw011

Huang, 2018, Chromium supplementation for adjuvant treatment of type 2 diabetes mellitus: Results from a pooled analysis, Mol. Nutr. Food Res., 62, 1700438, 10.1002/mnfr.201700438

Verkaaik, 1998, Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients, Diabet. Med., 15, 503, 10.1002/(SICI)1096-9136(199806)15:6<503::AID-DIA596>3.0.CO;2-M

Kostov, K. (2019). Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes: Focusing on the processes of insulin secretion and signaling. Int. J. Mol. Sci., 20.

Song, 2004, Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women, Diabetes Care, 27, 59, 10.2337/diacare.27.1.59

Wacher, 2008, Hypomagnesaemia and risk for metabolic glucose disorders: A 10-year follow-up study, Eur. J. Clin. Investig., 38, 389, 10.1111/j.1365-2362.2008.01957.x

2003, Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: A randomized double-blind controlled trial, Diabetes Care, 26, 1147, 10.2337/diacare.26.4.1147

Mooren, 2011, Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects—A double-blind, placebo-controlled, randomized trial, Diabetes Obes. Metab., 13, 281, 10.1111/j.1463-1326.2010.01332.x

El Derawi, W.A., Naser, I.A., Taleb, M.H., and Abutair, A.S. (2018). The effects of oral magnesium supplementation on glycemic response among type 2 diabetes patients. Nutrients, 11.

Fang, X., Wang, K., Han, D., He, X., Wei, J., Zhao, L., Imam, M.U., Ping, Z., Li, Y., and Xu, Y. (2016). Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: A dose-response meta-analysis of prospective cohort studies. BMC Med., 14.

Verma, 2017, Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: A systematic review and meta-analysis, J. Hum. Nutr. Diet., 30, 621, 10.1111/jhn.12454

Hannon, 2020, Use and abuse of dietary supplements in persons with diabetes, Nutr. Diabetes, 10, 14, 10.1038/s41387-020-0117-6

Low, 2021, Low muscle mass is associated with progression of chronic kidney disease and albuminuria—An 8-year longitudinal study in Asians with Type 2 Diabetes, Diabetes Res. Clin. Pract., 174, 108777, 10.1016/j.diabres.2021.108777

Ross, 2021, Lower body extremity function is associated with health-related quality of life: A cross-sectional analysis of overweight and obese older adults with and without type 2 diabetes mellitus, Qual. Life Res., 30, 2265, 10.1007/s11136-021-02821-5

Fragala, 2019, Resistance training for older adults: Position statement from the National Strength and Conditioning Association, J. Strength Cond. Res., 33, 2019, 10.1519/JSC.0000000000003230

Petroni, M.L., Caletti, M.T., Dalle Grave, R., Bazzocchi, A., Aparisi Gomez, M.P., and Marchesini, G. (2019). Prevention and treatment of sarcopenic obesity in women. Nutrients, 11.

Chapman, I., Oberoi, A., Giezenaar, C., and Soenen, S. (2021). Rational use of protein supplements in the elderly-Relevance of gastrointestinal mechanisms. Nutrients, 13.

Li, 2021, Diabetic kidney disease benefits from intensive low-protein diet: Updated systematic review and meta-analysis, Diabetes Ther., 12, 21, 10.1007/s13300-020-00952-5

Tu, D.Y., Kao, F.M., Tsai, S.T., and Tung, T.H. (2021). Sarcopenia among the elderly population: A systematic review and meta-analysis of randomized controlled trials. Healthcare, 9.

Osuka, Y., Kojima, N., Sasai, H., Wakaba, K., Miyauchi, D., Tanaka, K., and Kim, H. (2021). Effects of exercise and/or beta-hydroxy-beta-methylbutyrate supplementation on muscle mass, muscle strength, and physical performance in older women with low muscle mass: A randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr.

Manders, 2012, Insulinotropic and muscle protein synthetic effects of branched-chain amino acids: Potential therapy for type 2 diabetes and sarcopenia, Nutrients, 4, 1664, 10.3390/nu4111664

Hey, 2021, Nutraceuticals for the treatment of sarcopenia in chronic liver disease, Clin. Nutr. ESPEN, 41, 13, 10.1016/j.clnesp.2020.11.015

Kim, Y. (2021). Emerging treatment options for sarcopenia in chronic liver disease. Life, 11.

Beaudart, 2014, The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: A systematic review and meta-analysis of randomized controlled trials, J. Clin. Endocrinol. Metab., 99, 4336, 10.1210/jc.2014-1742

Bjelakovic, 2017, Vitamin D supplementation for chronic liver diseases in adults, Cochrane Database Syst. Rev., 11, CD011564

Braganca, 2010, Prevalence of diabetes mellitus and impaired glucose tolerance in patients with decompensated cirrhosis being evaluated for liver transplantation: The utility of oral glucose tolerance test, Arq. Gastroenterol., 47, 22, 10.1590/S0004-28032010000100005

Elkrief, 2016, Diabetes mellitus in patients with cirrhosis: Clinical implications and management, Liver Int., 36, 936, 10.1111/liv.13115

Kallwitz, 2015, Sarcopenia and liver transplant: The relevance of too little muscle mass, World J. Gastroenterol., 21, 10982, 10.3748/wjg.v21.i39.10982

Schiavo, 2018, Nutritional issues in patients with obesity and cirrhosis, World J. Gastroenterol., 24, 3330, 10.3748/wjg.v24.i30.3330

Brodosi, L., Petta, S., Petroni, M.L., Marchesini, G., and Morelli, M.C. (2021). Management of diabetes in candidates for liver transplantation and in transplant recipients. Transplantation, in press.

Colosimo, 2021, Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis, Liver Int., 41, 731, 10.1111/liv.14799

Vukotic, 2020, The effect of liraglutide on beta-blockade for preventing variceal bleeding: A case series, Ann. Intern. Med., 173, 404, 10.7326/L20-0041

Bischoff, 2020, ESPEN practical guideline: Clinical nutrition in liver disease, Clin. Nutr., 39, 3533, 10.1016/j.clnu.2020.09.001

Plank, 2008, Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: A randomized 12-month trial, Hepatology, 48, 557, 10.1002/hep.22367

Westerterp, 1995, Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: Effects of the pattern of food intake, Gut, 36, 110, 10.1136/gut.36.1.110

Baldassarre, M., Naldi, M., Zaccherini, G., Bartoletti, M., Antognoli, A., Laggetta, M., Gagliardi, M., Tufoni, M., Domenicali, M., and Waterstradt, K. (2021). Determination of effective albumin in patients with decompensated cirrhosis: Clinical and prognostic implications. Hepatology.

European Association for the Study of the Liver (2018). EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatol., 69, 406–460.

Caraceni, 2018, The use of human albumin in patients with cirrhosis: A European survey, Expert Rev. Gastroenterol. Hepatol., 12, 625, 10.1080/17474124.2018.1460203

Caraceni, 2018, Long-term albumin administration in decompensated cirrhosis (ANSWER): An open-label randomised trial, Lancet, 391, 2417, 10.1016/S0140-6736(18)30840-7

2015, Nutrition Intervention for advanced stages of diabetic kiidney disease, Diabetes Spectr., 28, 181, 10.2337/diaspect.28.3.181

Syauqy, A., Hsu, C.Y., Lee, H.A., Rau, H.H., and Chao, J.C. (2020). Association between dietary patterns and kidney function parameters in adults with metabolic syndrome: A cross-sectional study. Nutrients, 13.

Ko, G.J., Kalantar-Zadeh, K., Goldstein-Fuchs, J., and Rhee, C.M. (2017). Dietary approaches in the management of diabetic patients with kidney disease. Nutrients, 9.

Isaka, Y. (2021). Optimal protein intake in pre-dialysis chronic kidney disease patients with sarcopenia: An overview. Nutrients, 13.

Kidney Disease Ourcomes Quality Initiative (2007). KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am. J. Kidney Dis., 49, S12–S154.

Kalantar-Zadeh, K., Joshi, S., Schlueter, R., Cooke, J., Brown-Tortorici, A., Donnelly, M., Schulman, S., Lau, W.L., Rhee, C.M., and Streja, E. (2020). Plant-dominant low-protein diet for conservative management of chronic kidney disease. Nutrients, 12.

Tuttle, 2014, Diabetic kidney disease: A report from an ADA Consensus Conference, Am. J. Kidney Dis., 64, 510, 10.1053/j.ajkd.2014.08.001

Shapiro, 2011, Effects of polyunsaturated fatty acid consumption in diabetic nephropathy, Nat. Rev. Nephrol., 7, 110, 10.1038/nrneph.2010.156

Kong, 2016, Sodium and its role in cardiovascular disease—The debate continues, Front. Endocrinol., 7, 164, 10.3389/fendo.2016.00164

Abe, 2017, Is there a “burnt-out diabetes” phenomenon in patients on hemodialysis?, Diabetes Res. Clin. Pract., 130, 211, 10.1016/j.diabres.2017.06.012